Condition
Non Small Cell Lung Cancer|Advanced Triple Negative Breast Cancer|Small Cell Lung Cancer|Urothelial Cancer|Mesothelioma|Malignant Melanoma
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CASE2Y16
Study First Received: January 19, 2016
Last Updated: December 5, 2016
Estimated Primary Completion Date: July 2018
Primary Outcome Measures:
Dose Limiting Toxicity|Objective Response Rate for combination therapy|Median Duration of Response|Median time to tumor response|Median time of progression free survival|Median Overall Survival
Sponsors and Collaborators:
Case Comprehensive Cancer Center
Website Link: https://ClinicalTrials.gov/show/NCT02661100